T2 Biosystems (NASDAQ:TTOO) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report issued on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

Shares of NASDAQ:TTOO opened at $0.15 on Tuesday. T2 Biosystems has a 52-week low of $0.06 and a 52-week high of $6.80. The business’s 50 day moving average is $0.12 and its 200 day moving average is $0.28.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.